Search for: "Sherry" Results 341 - 360 of 3,247
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Dec 2010, 7:00 am by David Oscar Markus
Defense lawyers were: Mike Smith, Sherri Romano, Orlando do Campo, Len Fenn, Marty Feigenbaum, Scott Sakin, Peter Patanzo, and Israel Escinosa. [read post]
17 Feb 2008, 9:16 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. [read post]
7 Jan 2008, 8:48 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. [read post]
5 Oct 2021, 2:25 pm by Johanna Alonso
”  That is the best bet for getting women to return to the workforce post-pandemic, said Sherry Perkins, president of Anne Arundel Medical Center. [read post]
23 Apr 2007, 9:10 pm
This wonderful blog post is from a now 'defunct' blog called 'Stay of Execution' as the author, Sheherezade (Sherry Fowler) has 'shifted direction.' Sheherezade describes herself as a 'recovering lawyer.' She entered the blogosphere long before most of us knew... [read post]
6 Jan 2008, 9:07 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. [read post]
19 Apr 2016, 8:48 pm
Supreme Court set to weigh state's breath test law; The ruling in the case to be heard Wednesday could touch thousands of the state's motorists each year, attorneys say": Allison Sherry of The Minneapolis Star Tribune has this report. [read post]
26 Aug 2015, 6:26 pm by CrimProf BlogEditor
Sherri Lee Keene (University of Maryland Francis King Carey School of Law) has posted Victim or Thug? [read post]
30 Oct 2007, 9:16 pm
By Sherri Oslick -- In a nonprecedential opinion, the CAFC has affirmed the decision of the Board of Patent Appeals and Interferences dismissing the interference at issue after finding the appellant's claims invalid for failure to comply with the written description requirement of 35 U.S.C. [read post]
18 Sep 2007, 8:42 pm
By Sherri Oslick -- As reported here, on August 9, Eli Lilly filed suit in the District Court of New Jersey against Actavis Elizabeth in answer to Actavis' filing of an ANDA (and concomitant Paragraph IV certification) to manufacture a generic version of Lilly's Strattera ®. [read post]
19 Feb 2007, 1:41 pm
By Sherri Oslick A note to our readers: Patent Docs apologizes to our readers for the recent Court Report hiatus. [read post]
3 Feb 2008, 9:47 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. [read post]
7 Jun 2007, 7:39 pm
By Sherri Oslick -- On Wednesday, Amgen Inc. of Thousand Oaks, CA announced that it would acquire drug company Alantos Pharmaceuticals of Cambridge, MA for $300 million cash. [read post]
29 Mar 2007, 9:27 pm
By Sherri Oslick --- In a case testing the interplay between terminal disclaimers and patent term extensions under the Hatch-Waxman Act, the Federal Circuit, in affirming the judgment of the district court, held that patent term extensions could - nay should - be applied to terminally disclaimed patents, leaving Merck's... [read post]
28 Nov 2007, 8:53 pm
By Sherri Oslick -- Astellas Pharma Inc. of Tokyo, has announced an agreement between its U.S. subsidiary, Astellas U.S. [read post]
1 Feb 2008, 7:05 pm
By Sherri Oslick -- Last week, GlaxoSmithKline and Cypress Pharmaceutical filed a joint stipulation of dismissal in their pending lawsuit over generic Zantac ® syrup. [read post]
5 Aug 2007, 9:28 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. [read post]
4 May 2008, 8:42 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. [read post]